SCHEMBL1402304

SCHEMBL1402304

[CH2]C(CCC)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28212484 0.97
SCHEMBL11202838 0.82 ALDH1A1 (0.31)
SCHEMBL1524601 0.81
SCHEMBL1524958 0.79 OPRM1 (0.48)
SCHEMBL102296 0.78 METAP1 (0.36)
SCHEMBL9208085 0.77 OPRM1 (0.46)
SCHEMBL21052487 0.77 OPRM1 (0.46)
SCHEMBL21052334 0.77 OPRM1 (0.46)
SCHEMBL28154764 0.77 OPRM1 (0.46)
SCHEMBL11718763 0.77 OPRM1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
US-20240191009-A1 POLYFUNCTIONALIZED HIGH-CIS 1,4-POLYBUTADIENE AND METHOD FOR MANUFACTURING THE SAME KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2024-06-13 US disclosed
EP-4373529-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2024-05-29 EP disclosed
US-11978597-B2 Liquid component for electrolytic capacitor and electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2024-05-07 US disclosed
US-20240115745-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-04-11 US disclosed
CN-113164361-B Personal care compositions 高露洁-棕榄公司 2024-04-02 CN disclosed
CN-117769443-A Fibroblast activation protein inhibitor and use thereof 3B制药有限公司 2024-03-26 CN disclosed
WO-2024052431-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-03-14 WO disclosed
WO-2024043246-A1 ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE, WATER ELECTROLYSIS DEVICE, CARBON DIOXIDE ELECTROLYSIS DEVICE, FUEL CELL, AND PRODUCTION METHOD FOR ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE 三井化学株式会社 2024-02-29 WO disclosed
US-11826743-B2 Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2023-11-28 US disclosed
EP-1020439-A1 CETP ACTIVITY INHIBITORS JAPAN TOBACCO INC. (JP) 2000-07-19 EP disclosed
EP-0818512-A1 Quinoline derivative and use of same MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-01-14 EP disclosed
EP-0421441-B1 Pantothenic acid derivatives FUJIREBIO KK (JP) 1995-01-25 EP disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 US disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
US-4867784-A Cyclohexenone derivatives, preparation thereof and use thereof as herbicidal and plant growth regulator agents BASF AKTIENGESELLSCHAFT (DE) 1989-09-19 US disclosed
US-4549992-A Antihypertensive amides USV PHARMACEUTICAL CORP. (US) 1985-10-29 US disclosed
US-4435419-A Method of treating depression using azabicyclohexanes AMERICAN CYANAMID COMPANY (US) 1984-03-06 US disclosed
US-4026940-A CLEAVING TERT-BUTYL ESTER WITH STRONG ACID TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-05-31 US disclosed
US-3954826-A ANTIBACTERIAL INTERMEDIATES TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-05-04 US disclosed